NASDAQ Companies

Topline proof-of-concept results in ADH1 anticipated in 2021Currently, there are no approved therapies for ADH1PALO ALTO, Calif., Sept. 21, 2020 […]

$15 Million milestone triggered by initiation of Phase 3 clinical trial in NSCLC by IncyteROCKVILLE, MD, Sept. 21, 2020 (GLOBE […]

DURHAM, N.C. and STAMFORD, Conn., Sept. 21, 2020 (GLOBE NEWSWIRE) — Precision BioSciences, Inc. (Nasdaq: DTIL), a clinical stage biotechnology […]

—Live presentation highlighting TRV027 as a potential treatment for COVID-19 acute respiratory distress syndrome (ARDS) / abnormal clottingPosters on OLINVYK […]

Single Phase 3 trial to be conducted to support an NDA filing of AXS-12 in the treatment of narcolepsy; trial […]

MENLO PARK, Calif. and BOSTON, Sept. 21, 2020 (GLOBE NEWSWIRE) — Adicet Bio, Inc. (“Adicet”) (Nasdaq: ACET), a biotechnology company […]

LATHAM, N.Y., Sept. 21, 2020 (GLOBE NEWSWIRE) — Plug Power Inc. (NASDAQ: PLUG), a leading provider of clean hydrogen and […]

SOUTHBOROUGH, Mass., Sept. 21, 2020 (GLOBE NEWSWIRE) — Virtusa Corporation (NASDAQ GS: VRTU), a global provider of digital strategy, digital […]

CAESAREA, Israel, Sept. 21, 2020 (GLOBE NEWSWIRE) — Itamar Medical Ltd. (NASDAQ and TASE: ITMR), a leading medical device and […]

AMRYT PHARMA PLC(“Amryt” or the “Company”)Exercise of Warrants & Issue of Ordinary Shares and Total Voting RightsDUBLIN, Ireland, and Boston […]